RNA vaccine - Wikipedia
COVID-19 tracker: Pfizer, Moderna vaccines sharply cut hospitalizations in older adults, CDC data show | FiercePharma
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
mRNA vaccines — a new era in vaccinology | Nature Reviews Drug Discovery
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery: Molecular Therapy
SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness | bioRxiv
Frontiers | From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape | Immunology
COVID-19 vaccine: the eight technologies being tested | IVVN
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination | Science Immunology
Vaccines | Free Full-Text | An Update on Self-Amplifying mRNA Vaccine Development | HTML
Healthcare Provider Q&A
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | NEJM
Frontiers | Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections | Immunology
Vaccines | Free Full-Text | A Descriptive-Multivariate Analysis of Community Knowledge, Confidence, and Trust in COVID-19 Clinical Trials among Healthcare Workers in Uganda | HTML
mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability - ScienceDirect
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
COVID-19 tracker: Regeneron's antibody cocktail hit by safety concerns; Novo's Rybelsus emerging from pandemic slump | FiercePharma
